Cartesian Therapeutics, Inc. · NASDAQ:RNAC
Barclays PLC reported a 5.99% stake in Cartesian Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 13, 2026
Barclays PLC reported a 5.99% stake in Cartesian Therapeutics, Inc., 1,760,326 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).
- Stake
- 5.99%
- Shares
- 1,760,326
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 5.99% | 1,760,326 |